Trial Profile
Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2021
Price :
$35
*
At a glance
- Drugs Telavancin (Primary)
- Indications Renal failure
- Focus Pharmacokinetics
- 06 Oct 2021 Results characterizing telavancin pharmacokinetics in patients receiving haemodialysis published in the Journal of Antimicrobial Chemotherapy
- 25 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Jul 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.